Providing input and support on companion animal (dog, cat and horse) pre-clinical, proof of concept, client owned efficacy studies, animal efficacy models and translational work. Expertise includes study design, enrollment criteria, efficacy endpoints, study success criteria, live phase study conduct (including over sight and hands on), study monitoring, technical writing, project management, study planning and preparation, site selection (CROs and Universities), Vast experience in many therapeutic areas including osteoarthritis, kidney disease, dermatitis, otitis externa, oncology, diabetes, pain, etc. Able to provide flexible staffing options and creative ideas to help partners move projects faster and more efficiently. Multi-tasking, independent work environment, communication and attention to details are all strengths. Strong network throughout the Animal Health industry, veterinary teaching hospitals and animal health contract research organizations.Karen NewhallACADIAN LLCHelping move animal health research projects forward for tomorrow’s pets765.960.5081newhallkb@gmail.com

Monitored clinical trial sites for companion animal parasiticides and therapeutics. Trained veterinary clinic staff on study protocols, GCP and electronic data capture systems.

Evaluate new opportunities in Companion Animal Therapeutics for Elanco Animal Health, a division of Eli Lilly and Company. I conduct technical reviews, design and execute pilot efficacy, safety and ADME studies, interpret data and move projects through internal stage gates.

Seek, evaluate and develop new opportunities for Companion Animal Therapeutics.